Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors Life Science Investing
Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity Platform Life Science Investing
Sangamo Therapeutics to Present Pipeline and Technology Advances at the 29th Annual Meeting of The American Society of Gene & Cell Therapy Life Science Investing
CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026 Life Science Investing
Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities Life Science Investing
ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026 Life Science Investing
Cizzle Brands Corporation Recognized by UNFI Canada as One of the Fastest-Growing Brands in its Network; Appoints CPG Veteran David Giancoulos to Board of Directors Biotech Investing
Palvella Therapeutics to Host First Quarter 2026 Financial Results and Corporate Update Conference Call on May 7, 2026 Life Science Investing
Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026 Life Science Investing
Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference Medical Device Investing
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington's Disease Life Science Investing
Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update Life Science Investing
